Highest Ranking Oral Abstracts

Neuromodulation is moving from a single-device "one target, one therapy" model to an integrated approach where SCS, DRG stimulation, and PNS are selected and combined based on pain phenotype, coverage needs, and durability goals. This panel will examine how and when to deploy multimodal neuromodulation strategies in chronic pain, the evidence supporting component modalities, and how closed-loop/adaptive systems and programming approaches may reduce failures and reinterventions. The discussion will emphasize practical clinical algorithms, evidence gaps, and real-world outcomes needed to support broader adoption.